Claims for Patent: 7,482,015
✉ Email this page to a colleague
Summary for Patent: 7,482,015
| Title: | Optimized expression of HPV 45 L1 in yeast |
| Abstract: | Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity. |
| Inventor(s): | Janine T. Bryan, Michelle K. Brownlow, Loren D. Schultz, Kathrin U. Jansen |
| Assignee: | Merck Sharp and Dohme LLC |
| Application Number: | US11/805,453 |
Details for Patent 7,482,015
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | GARDASIL 9 | human papillomavirus 9-valent vaccine, recombinant | Injection | 125508 | December 10, 2014 | ⤷ Start Trial | 2027-05-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,482,015
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 045804 | ⤷ Start Trial |
| Argentina | 077396 | ⤷ Start Trial |
| Austria | E435029 | ⤷ Start Trial |
| Australia | 2004277934 | ⤷ Start Trial |
| Belgium | 2015C072 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
